Vivimed Labs, currently undergoing the Corporate Insolvency Resolution Process (CIRP), has scheduled its 7th Committee of Creditors meeting for September 10, 2026. This meeting, conducted via audio-visual means, marks a continued step in the insolvency process initiated by the NCLT on April 15, 2026. Shareholders should remain cautious as the company navigates this high-risk resolution phase, with future outcomes dependent on the CoC’s decisions regarding a potential resolution plan or liquidation.
Vivimed Labs Schedules 7th Committee of Creditors Meeting
Meeting Date: September 10, 2026.
Regulatory Status: Ongoing Corporate Insolvency Resolution Process (CIRP).
Reader Takeaway: The insolvency process remains active; shareholders face high uncertainty regarding the final resolution plan outcome.
What just happened
Vivimed Labs Limited has formally notified the stock exchanges that its 7th Committee of Creditors (CoC) meeting will take place on September 10, 2026. The meeting will be held via audio-visual means, adhering to the standard protocols defined by the Insolvency and Bankruptcy Board of India (IBBI). T Narayana Swamy, the appointed Interim Resolution Professional, is overseeing the proceedings.
Why this matters
For retail investors, this meeting is a critical data point in the company's survival roadmap. Since the NCLT admitted the company into insolvency on April 15, 2026, the power of the board of directors has been suspended. The CoC now holds the primary decision-making authority over the company’s future, including whether a viable resolution plan can be implemented or if the firm will proceed toward liquidation.
The backstory
Vivimed Labs faced financial headwinds that led to the invocation of the Insolvency and Bankruptcy Code (IBC). The company has been providing regular updates to stakeholders as the resolution process moves through the statutory phases mandated by the NCLT order.
Risks to watch
Equity remains in a highly volatile state. Under CIRP, the value for existing shareholders is typically determined only after the claims of financial creditors, operational creditors, and the costs of the insolvency process are addressed. There is a significant risk that the resolution plan may result in substantial value erosion for equity holders.
What to track next
Investors should closely watch for subsequent exchange filings detailing the outcome of the 7th CoC meeting. Key updates to look for include news on potential bids for the company, the status of the information memorandum, or any official transition toward a final resolution plan.